Clinical trial
The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the…
NCT00240279 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00240279 |
|---|---|
| Title | The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study |
| Official title | The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug, Procedure |
| Interventions | Rosuvastatin, aortic pulse wave velocity measurements |
| Enrollment | 10 |
| Start date | Jan 1, 2003 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Oct 18, 2005 |
| Last update posted | Nov 19, 2010 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: